Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry [Phase 3]
Phase 3 trial investigating the effects of linagliptin on left ventricular dysfunction in patients with type 2 diabetes and concentric left …
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D) [NA]
Clinical trial update for duodenal mucosal resurfacing (DMR) with the Revita system in type 2 diabetes shows completed status with results p…
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Regulatory Request NIS in Korea
Clinical trial update noting regulatory request in Korea for a study involving Type 2 diabetes; study completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes [Phase 2]
Phase 2 trial update for tirzepatide (LY3298176) in adults with type 2 diabetes; study completed with results posted in 2021.
-
CLINICAL_TRIALS research · 2021-05-18Clinical Trial Update: Pharmacogenomics of Thiazolidinediones [NA]
Pharmacogenomics-focused clinical trial update on thiazolidinediones in type 2 diabetes has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-05-17FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Laurus Labs Limited)
FDA approved a supplemental application for Metformin Hydrochloride by Laurus Labs Limited under ANDA 209882; this action updates/expands th…
-
FDA approval · 2021-05-16FDA Approved: GLIPIZIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for glipizide submitted by Actavis Pharma, Inc., under an ANDA.
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes [Phase 2]
Phase 2 trial update for an anti-inflammatory small-molecule adjunctive therapy in type 2 diabetes shows completed results.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin [Phase 3]
Phase 3 trial evaluating sotagliflozin versus placebo and empagliflozin in adults with type 2 diabetes inadequately controlled on a DPP-4 in…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Metformin [Phase 3]
Phase 3 trial updating efficacy and safety of sotagliflozin vs placebo in adults with type 2 diabetes on metformin.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy [Phase 3]
Phase 3 trial comparing sotagliflozin to glimepiride and placebo as add-on to metformin in type 2 diabetes; results completed with posted da…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With Metformin [Phase 3]
Phase 3 trial update on sotagliflozin vs placebo in type 2 diabetes patients on sulfonylurea, with or without metformin, reporting efficacy …
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes Mellitus
Post-marketing surveillance trial update for JARDIANCE in Korean adults with type 2 diabetes; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic Agents [Phase 3]
Phase 3 trial assessing sotagliflozin versus placebo in type 2 diabetes with inadequate glycemic control on insulin +/- other agents; result…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Therapy of the Skeletal Disease of Type 2 Diabetes With Denosumab [Phase 2]
A Phase 2 trial evaluating denosumab for skeletal disease in type 2 diabetes was terminated, with results posted in May 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating rivoglitazone versus placebo and active comparator in patients with Type 2 Diabetes.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic Impairment [Phase 1]
Phase 1 trial examining safety and efficacy of bexagliflozin in subjects with moderate hepatic impairment; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: Surgery or Lifestyle With Intensive Medical Management in the Treatment of Type 2 Diabetes [NA]
Clinical trial comparing surgery or lifestyle with intensive medical management for type 2 diabetes and obesity; completed with results post…
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes [Phase 4]
Phase 4 trial assessing the effect of neprilysin on GLP-1 in patients with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: Quadruple Oral Combination Therapy for Type 2 Diabetes Mellitus : Glycemic Control by Thiazolidinedione (TZD) or Sodium Glucose Co-transporter 2 (SGLT-2) Inhibitor as an add-on Therapy in Type 2 Diabetes Mellitus After Failure of an Oral Triple Antidiabetic Regimen [Phase 4]
Phase 4 trial evaluating quadruple oral combination therapy for Type 2 Diabetes Mellitus as add-on after failure of an oral triple regimen, …
-
FDA approval · 2021-04-30FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
The FDA approves a supplemental application for OZEMPIC to support the oral semaglutide formulation.
-
FDA approval · 2021-04-30FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for metformin hydrochloride submitted by Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide) [Phase 4]
Phase 4 PK/PD study of Glufast tablets 10mg (mitiglinide) completed.
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy [Phase 4]
Phase 4 trial comparing metabolic responses of dapagliflozin versus sitagliptin in Type 2 Diabetes patients inadequately controlled with ins…
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases [Phase 4]
Phase 4 clinical trial update evaluating efficacy and safety of Evoglitin in patients with type 2 diabetes and non-alcoholic fatty liver dis…